The sequence, phenotype and environmental data for many people are accessible to researchers through each separate study. However, combining the data in a broadly accessible central database would allow researchers to address many questions more efficiently and with more power, including discovering rare variants and common variants with small effects on phenotypes or disease risk. Such a resource could support many studies of disease biology and drug target validation.
The workshop addressed the challenges to aggregating and analyzing data sets from genome sequencing studies, such as:
All documents are in format
Last Reviewed: March 14, 2014